Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Reset Form
Corey J. Langer, MD

Corey J. Langer, MD Physician

Director, Thoracic Oncology Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Langer is employed by Penn Medicine.

About Dr. Corey J. Langer

Recognized by America's Top Doctors, 2008, 2010 - 2018

Recognized by Best Doctors in America 2009, 2010, 2013 - 2018

Recognized annually in Philadelphia magazine's Top Docs issue, 2009 - 2019

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1987

Clinical Expertise:

  • Adenocarcinoma of Lung
  • Adenocarcinoma of the Head and Neck
  • Adenoid Cystic Carcinoma
  • Anaplastic Cancer of Thyroid
  • Base of Skull Tumors
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Cancer of the Hard/Soft Palate
  • Cancer of the Nasal Cavity
  • Cancer of the Parotid
  • Cancer of the Supraglottis
  • Cancer of the Vocal Cords
  • Diaphragm Tumor
  • Ear and Temporal Bone Tumors
  • Esophageal Cancer
  • Follicular Cancer of Thyroid
  • Glottic Cancer
  • Head and Neck Melanoma
  • Head and Neck Sarcoma
  • Head and Neck Tumor
  • Hurthle Cell Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • Jaw Cancer
  • Large Cell Cancer of the Lung
  • Laryngeal Cancer
  • Lung Carcinoid Tumor
  • Medullary Cancer of Thyroid
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Mouth Cancer (Oral Cancer)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Papillary Cancer of Thyroid
  • Parathyroid Cancer
  • Pituitary Cancer
  • Pleural Cancer
  • Salivary Gland Cancer
  • Sarcoma of the Lung
  • Sinus Cancer
  • Small Cell Lung Cancer
  • Squamous Cancer of the Lung
  • Squamous Cell Carcinoma of the Esophagus
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma of the Mouth
  • Squamous Cell Carcinoma of the Throat
  • Squamous Cell Carcinoma of the Tonsils
  • Temporal Bone Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Tongue Cancer
  • Tonsil Cancer
  • Tracheal Cancer
  • Tumor of Parotid Gland
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Boston University School of Medicine
Residency: Graduate Hospital
Fellowship: Penn Presbyterian Medical Center
Fellowship: Fox Chase Cancer Center

Memberships

American Association for Cancer Research, (Member), National American College of Physicians, National American College of Surgeons Head and Neck Database Committee, National American Society of Clinical Oncology, National BMS Advisory Board on Ipilimumab, National Eastern Cooperative Oncology Group (ECOG), Member of Elderly Working Group, National International Association for Study of Lung Cancer, International Lung Cancer Partnership, Local National Comprehensive Cancer Network Non-Small Cell Lung Cancer Panel, National National Comprehensive Cancer Network Small Cell Lung Cancer Panel, National Oncology Physician Network (OPN), Inc., Philadelphia, Local Pennsylvania Medical Society, Local Pharmacyclics Advisory Board, National Program Committee of the International Association of Lung Cancer, International

Hospital Affiliation

Dr. Langer is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Gadgeel SM, Stevenson JP, Langer CJ, Gandhi L, Borghaei H, Patnaik A, Villaruz LC, Gubens M, Hauke R, Yang JC, Sequist LV, Bachman R, Saraf S, Raftopoulos H, Papadimitrakopoulou V.: Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study Lung Cancer. 2018 Nov;125:273-281. 125 : 273-281,2018.

Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani A, Langer C, Albelda S., : Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. Lung Cancer. 2017 Oct;112:118-125. : 2018.

Camidge DR, Kim DW, Tiseo M, Langer CJ, Ahn MJ, Shaw AT, Huber RM, Hochmair MJ, Lee DH, Bazhenova LA, Gold KA, Ou SI, West HL, Reichmann W, Haney J, Clackson T, Kerstein D, Gettinger SN.: Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials. J Clin Oncol. 2018 Sep 10;36(26):2693-2701. : 2018.

Hirsh V, Wan Y, Lin FJ, Margunato-Debay S, Ong TJ, Botteman M, Langer C.: Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin. Clin Lung Cancer. 2018 Sep;19(5):401-409. : 2018.

Chu CY, Choi J, Eaby-Sandy B, Langer CJ, Lacouture ME., : Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer. Oncologist. 2018 Aug;23(8):891-899. : 2018.

Katz SI, Hammer M, Bagley SJ, Aggarwal C, Bauml JM, Thompson JC, Nachiappan AC, Simone CB 2nd, Langer CJ.: Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2018 Jul;13(7):978-986. : 2018.

Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, PĂ©rol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N.: Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies. Clin Lung Cancer. 2018 Jul;19(4):331-339. : 2018.

Katz SI, Hammer M, Bagley SJ, Aggarwal C, Bauml JM, Thompson JC, Nachiappan AC, Simone CB 2nd, Langer CJ., : Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2018 Jul;13(7):978-986. : 2018.

Langer CJ, Kim ES, Anderson EC, Jotte RM, Modiano M, Haggstrom DE, Socoteanu MP, Smith DA, Dakhil C, Konduri K, Berry T, Ong TJ, Sanford A, Amiri K, Goldman JW, Weiss J; ABOUND.70+ Investigators.: nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC. Front Oncol. 2018 Jul 24;8:262. : 2018.

Bonomi P, Blumenthal G, Ferris AS, Stewart DJ, Selig WKD, Krug LM, Allen J, Ison G, Langer CJ, Melemed A, Odogwu L, Basu Roy U, Sandler A.: Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria. J Thorac Oncol. 2018 Jun;13(6):748-751. : 2018.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-206
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 615-5121
Patient appointments: 800-789-7366 (PENN)

Related Links